New antineoplastic agent, MK615, from UME (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro

Breast Journal

Volumn 13, Issue 1, 2007, Pages 44-49

  Nakagawa, Aya ^a   Sawada, Tokihiko ^a   Okada, Toshie ^a   Ohsawa, Tatsushi ^b   Adachi, Masakazu ^b   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Japan Apricot Co Ltd   (Japan)

Author keywords

Breast cancer; Japanese apricot; MK615

Indexed keywords

INDOMETACIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRUCTURE; DOSE RESPONSE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MICROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; FEMALE; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PRUNUS;

EID: 33845977334     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2006.00361.x     Document Type: Article

References (13)

1. Hortobagyi GN, Salazar Jde L, Pritchard K et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005;6:391-401.
2. Tubiana-Hulin M. How to maximize the efficacy of taxanes in breast cancer. Cancer Treat Rev 2005;31(Suppl. 4):S3-9.
3. Perez EA, Suman VJ, Rowland KM et al. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-weeks schedule) as first-line therapy in women with HER2-overexpressing metastasis breast cancer: NCCTG Study 983252. Clin Breast Cancer 2005;6:425-32.
4. Saeki T, Tsuruo T, Sato W, Nishikawsa K. Drug resistance in chemotherapy for breast cancer. Cancer Chemother Pharmacol 2005;56(Suppl. 7):84-89.
5. Xu R, Fazio GC, Matsuda PT. On the origins of triterpenoid skeletal diversity. Phytochemistry 2004;65:261-91.
6. Gutterman JU, La HT, Yang P, Haridas V, Gaikwad A, Marcus S. Effects of the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and protein ubiquitination in fission yeast. Proc Nat Acad Sci USA 2005;102:12771-76.
7. Ramachandran C, Rabi T, Fonseca HB, Melnick SJ, Escalon EA. Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines. Cancer Cell Biol 2003;105:784-89.
8. Adachi M, Suzuki Y, Mizuta T et al. The Japanese apricot Prunus mume Sieb. et Zucc (Ume) is a rich natural source of novel anti-cancer substance. Int J Food Prop 2006:in press.
9. Sun HX, Zheng QF, Tu J. Induction of apoptosis in HeLa cells by 3beta-hydroxy-12-oleanen-27-oic acid from the rhizomes of Astilbe chinensis. Bioorg Med Chem 2006;14:1189-98.
10. Marumoto T, Zhang D, Saya H. Aurora A - a guardian of poles. Nat Rev Cancer 2005;5:42-50.
11. Jakubikova J, Sedlak J, Bacon J, Goldson A, Bao Y. Effects of MEK1 and PI3K inhibitors on allyl-, benzyl- and phenylethylisothiocyanate-induced G2/M arrest and cell death in Caco-2 cells. Int J Oncol 2005;27:1449-58.
12. Gapter L, Wang Z, Glinski J, Ng KY. Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun 2005;332:1153-61.
13. Konopleva M, Tsao T, Estrov Z et al. The synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Cancer Res 2004;64:7927-35.